(0.51%) 5 214.08 points
(0.85%) 39 388 points
(0.27%) 16 346 points
(0.48%) $79.64
(0.56%) $2.31
(0.57%) $2 353.60
(0.72%) $28.57
(0.45%) $995.30
(0.04%) $0.928
(-0.18%) $10.85
(0.02%) $0.799
(0.01%) $92.55
2.92% $ 0.155
Live Chart Being Loaded With Signals
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally...
Stats | |
---|---|
Dzisiejszy wolumen | 575 336 |
Średni wolumen | 442 660 |
Kapitalizacja rynkowa | 2.42M |
EPS | $0 ( 2024-02-13 ) |
Następna data zysków | ( $-0.170 ) 2024-06-19 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.190 |
ATR14 | $0.00300 (1.94%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-29 | Trombly Amy Moss | Buy | 60 000 | Stock option (right to buy) |
2023-12-29 | Thornton Bruce | Buy | 60 000 | Stock option (right to buy) |
2023-12-29 | Dal Poggetto John | Buy | 50 000 | Stock option (right to buy) |
2023-12-29 | Dvonch Jerome J | Buy | 60 000 | Stock option (right to buy) |
2023-07-17 | Dal Poggetto John | Sell | 5 000 | Stock option (right to buy) |
INSIDER POWER |
---|
85.74 |
Last 96 transactions |
Buy: 1 783 187 | Sell: 474 451 |
Wolumen Korelacja
Sonoma Pharmaceuticals Korelacja
10 Najbardziej pozytywne korelacje | |
---|---|
USEG | 0.871 |
ISUN | 0.863 |
HOOK | 0.862 |
IONS | 0.837 |
GRAY | 0.836 |
TCRT | 0.835 |
PLXP | 0.832 |
PRSO | 0.831 |
LQDT | 0.83 |
NEPT | 0.829 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Sonoma Pharmaceuticals Korelacja - Waluta/Towar
Sonoma Pharmaceuticals Finanse
Annual | 2023 |
Przychody: | $13.27M |
Zysk brutto: | $4.48M (33.73 %) |
EPS: | $-1.520 |
FY | 2023 |
Przychody: | $13.27M |
Zysk brutto: | $4.48M (33.73 %) |
EPS: | $-1.520 |
FY | 2022 |
Przychody: | $12.63M |
Zysk brutto: | $3.99M (31.62 %) |
EPS: | $-1.920 |
FY | 2021 |
Przychody: | $18.63M |
Zysk brutto: | $6.56M (35.21 %) |
EPS: | $-1.970 |
Financial Reports:
No articles found.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for wound care, animal health care, eye care, oral care, and dermatological conditions in the United States, Latin America, Europe, and internationally. The company offers Epicyn, an antimicrobial facial cleanser; Levicyn, an HOCl based prescription product to manage and relieve burning, itching, and pain experienced with various types of dermatoses; Celacyn gel, a HOCl-based topical prescription product indicated to promote efficient healing through the management of new and old scars; and SebuDerm to manage and relieve the burning, itching, erythema, scaling, and pain associated with seborrhea and seborrheic dermatitis. It also provides Acuicyn, a HOCl-based product indicated to relieve itch and inflammation while helping to keep areas around the eye clean; and Microcyn, a HOCl-based topical line of products designed to stimulate expedited healing by targeting a wide range of pathogens, as well as antibiotic-resistant strains that slow the natural healing of wounds. In addition, the company offers MicrocynAH, an HOCl-based solution designed to relieve common symptoms of hot spots, scratches, skin rashes post-surgical sites, and irritated animal skin for healing; Microdacyn60 oral care solution for the treatment of mouth and throat infections; MucoClyns for the use in emergencies and safe to use on mucous membranes, cuts, abrasions, burns, and body surfaces; Endocyn root canal irrigation solutions; Pediacyn atopic dermatitis hydrogel; Ocucyn eyelid and eyelash cleanser; Gramaderm for the treatment of topical mild to moderate acne; Nanocyn, a hospital-grade disinfectant; and Sinudox for nasal irrigation. The company was formerly known as Oculus Innovative Sciences, Inc. and changed its name to Sonoma Pharmaceuticals, Inc. in December 2016. Sonoma Pharmaceuticals, Inc. was incorporated in 1999 and is based in Woodstock, Georgia.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej